The move comes alongside a mutual decision with Xeris BioPharma Holdings, Inc. (Nasdaq: XERS) to return the commercial rights to Ogluo®, a glucagon auto-injector pen for severe hypoglycemia. The ...

adding that it had mutually agreed with Xeris BioPharma to return the rights to Ogluo - a ready-to-use glucagon auto-injector for severe hypoglycemia. The AIM-traded firm said the decision ...

Commissions do not affect our editors' opinions or evaluations. We like Auto-Owners’ range of coverage offerings, which include an optional diminishing deductible that reduces your policy ...

From L.A. and Detroit to Geneva and Tokyo, MotorTrend covers every major auto show in the world as it happens. Although some shows are changing, others are ending, and new ones emerging ...

If you’re looking for auto insurance reviews, you’ve come to the right place. NerdWallet has researched policy options, consumer complaint data, customer satisfaction ratings, financial ...

It’s the most talked about vehicle of 2024. Something many of us have been waiting for. After being teased for years, it’s finally here. No, we’re not referring to a certain, polarizing ...

Auto-Owners Insurance works with independent agents to sell vehicle coverage policies, as well as home, life and business insurance. The company operates in 26 states, and it provides some ...

At completion, patients can take the 100 mg/mL Leqembi injection at home, which takes about 15 seconds. This could potentially reduce the need for hospital and infusion site visits. Infusion-related ...

The injection process is expected to take, on average, 15 seconds. As part of the SC-AI 360 mg weekly maintenance regimen, patients who have completed the biweekly intravenous (IV) initiation ...

It has been estimated that 90% of medical device waste consists of single-use products or components, so a new initiative by Novo Nordisk to recycle pre-filled injection pens used by people living ...